[1]
2024. Challenges in managing lisdexamfetamine dimesylate in the treatment of Attention Deficit Hyperactivity Disorder. Electronic Journal Collection Health. 24, 12 (Dec. 2024), e17434. DOI:https://doi.org/10.25248/reas.e17434.2024.